"Big Data" in the life sciences sector is now a strategic opportunity for all researchers, and the benefits may soon be captured by all stakeholders and society. Companies who can exploit Big Data and advanced analytics when developing new products will have the potential to improve the competitiveness, productivity & efficiency of R&D in order to better demonstrate clinical benefit and improved outcomes.

4 Events in One:

  • Strategic Development in R&D Big Data
  • Discovery and Omics Data Excellence
  • Clinical Data Management & Technology
  • R&D IT & Bioinformatics

This 3 day forum is the "must attend" event for those senior decision-makers looking to make the shift towards a dedicated big data strategy and for those looking to improve their implementation of data-driven approaches to enhance R&D decision-making.

Further details can be found at http://bigdata2016.nextlevelpharma.com/ or request agenda at http://bigdata2016.nextlevelpharma.com/request-agenda or contact me directly for more information.

Anastasia Ratnikova
NextLevel Pharma
Ph: +421 2 3266 0382
Fax: +421 2 3301 0331
anastasiar@nextlevelpharma.com